Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Atrial Fibrillation
Trial Locations (22)

Unknown

Boehringer Ingelheim Investigational Site, Aurora

Boehringer Ingelheim Investigational Site, New Britain

Boehringer Ingelheim Investigational Site, Orlando

Boehringer Ingelheim Investigational Site, Tampa

Boehringer Ingelheim Investigational Site, New Orleans

Boehringer Ingelheim Investigational Site, Springfield

Boehringer Ingelheim Investigational Site, Chesterfield

Boehringer Ingelheim Investigational Site, St Louis

Boehringer Ingelheim Investigational Site, Hackensack

Boehringer Ingelheim Investigational Site, New York

Boehringer Ingelheim Investigational Site, Staten Island

Boehringer Ingelheim Investigational Site, Philedelphia

Boehringer Ingelheim Investigational Site, Nashville

Boehringer Ingelheim Investigational Site, Charlottesville

Boehringer Ingelheim Investigational Site, Norfolk

Boehringer Ingelheim Investigational Site, Roanoke

Boehringer Ingelheim Investigational Site, Calgary

Boehringer Ingelheim Investigational Site, Vancouver

Boehringer Ingelheim Investigational Site, Saint John

Boehringer Ingelheim Investigational Site, Halifax

Boehringer Ingelheim Investigational Site, Hamilton

Boehringer Ingelheim Investigational Site, Montreal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY